Bank Of America Corp Codex Dna, Inc. Transaction History

Bank Of America Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	N/A	-9 Reduced 0.15%	6,000 $11,000
Q4 2023 Feb 14, 2024	BUY	N/A	9 Added 0.15%	6,009 $11,000
Q1 2023 May 12, 2023	SELL	$1.3 - $2.15 $28 - $47	-22 Reduced 0.37%	6,000 $11,000
Q4 2022 Feb 10, 2023	SELL	$1.12 - $1.69 $722 - $1,090	-645 Reduced 9.67%	6,022 $7,000
Q3 2022 Nov 14, 2022	BUY	$1.7 - $2.36 $9,273 - $12,873	5,455 Added 450.08%	6,667 $11,000
Q2 2022 Aug 12, 2022	SELL	$1.8 - $6.45 $76,035 - $272,460	-42,242 Reduced 97.21%	1,212 $2,000
Q1 2022 May 16, 2022	BUY	$4.12 - $10.36 $156,560 - $393,680	38,000 Added 696.74%	43,454 $233,000
Q4 2021 Feb 08, 2022	BUY	$6.31 - $11.96 $31,209 - $59,154	4,946 Added 973.62%	5,454 $59,000
Q3 2021 Nov 15, 2021	BUY	$10.15 - $19.88 $5,156 - $10,099	508 New	508 $6,000

307

Ticker DNAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,518,200
Market Cap $54.6M
Description
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.